Here are relevant reports on : e-discovery-market
-
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030
The global proteomics market, valued at US$33.63 billion in 2024, stood at US$36.32 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$65.80 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030
The next-generation sequencing market, valued at US$13.95 billion in 2024, stood at US$14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Microscopy Market by Product (Optical Microscope: Stereo, Digital; Electron Microscope: SEM, TEM; AFM, STM), Application (Pharma Mfg., Pathology, Drug Discovery, Toxicology), End User (Pharma-Biopharma, F&B, Academia, Semiconductor) - Global Forecasts to 2031
The global microscopy market, valued at US$8.35 billion in 2024, stood at US$8.81 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2031, culminating in a forecasted valuation of US$11.44 billion by the end of the period. The global microscopy market plays a very important and enabling part in the life sciences and research community, and its applications beyond biologic imaging are growing very rapidly in semiconductor device manufacturing.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Social TV Market [Social EPG, Content Discovery, Social Analytics, Social Curation, AD Platforms]: Global Advancements, Ecosystem, Business Models, Technology Roadmap, Worldwide Market Forecasts & Analysis (2012 – 2017)
Social TV Market is set to take the television industry by storm as television manufacturers are betting big money in this technology. There exists a diversity of players in the Social TV ecosystem, as the industry is open to experiments and is witnessing many a tie-ups between broadcasters and social networking companies. While some broadcasters are amalgamating Social TV within their own platforms; there are many, who are integrating Twitter into their Social TV platforms for enhanced custom experience and participation. Industry players such as BBC and CNN, on the other hand have signed deals with social networking players such as Facebook, as social networking companies are aggressively trying to venture into this space.
- Published: October 2012
- Price: $ 4950
- TOC Available:
-
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030
The global lab automation market, valued at US$5.97 billion in 2024, stood at US$6.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.2% from 2025 to 2030, culminating in a forecasted valuation of US$9.01 billion by the end of the period. The primary driver of this growth is the increasing demand for high-throughput screening, which enables laboratories to efficiently process large volumes of samples in drug discovery and diagnostics.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Cancer Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
The global cancer profiling market in terms of revenue was estimated to be worth $9.7 billion in 2022 and is poised to reach $16.0 billion by 2027, growing at a CAGR of 10.6% from 2022 to 2027. The growth in this market is driven by rising funding investments in cancer research and technological advancements in profiling technologies. In addition, the growing need for point-of-care diagnostics is expected to offer significant growth opportunities for market players. On the other hand, a low biomarker discovery-to-approval ratio and a poor regulatory and reimbursement scenario challenge the growth of the cancer profiling market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
US Operational Technology (OT) Security Market by Solutions (Asset Discovery & Management, Network Security, Vulnerability Management, IAM, Data Security), Services (Incident Response, Managed, Consulting & Integration) - Forecast to 2030
The US operational technology (OT) security market is projected to grow from USD 4.64 billion in 2025 to USD 9.37 billion by 2030 at a CAGR of 15.1% during the forecast period.The Key Players Nozomi Networks (US), Dragos (US), Stellar Cyber (US), Armis (US), Forescout (US), Tenable (US), Claroty (US), Rockwell Automation (US), TXOne Networks (US), Radiflow (US), Industrial Defender (US), Armexa (US), Cisco (US), IBM (US), and Fortinet (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030
Global digital pathology market valued at $1.30B in 2024, reached $1.46B in 2025, and is projected to grow at a robust 13.5% CAGR, hitting $2.75B by 2030. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023
The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
